Levetiracetam and brivaracetam modulate synaptic neurotransmitter release by binding to synaptic vesicle protein 2A (SV2A).

Ethosuximide acts on T-type calcium channels. Many anti-seizure drugs block sodium channels. Vigabatrin inhibits GABA transaminase. Perampanel is an AMPA receptor antagonist.